Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Article 2019 en
Authors
JT
Jean‐Claude Tardif
SK
Simon Kouz
DW
David D. Waters
Abstract
1 min read
Among patients with a recent myocardial infarction, colchicine at a dose of 0.5 mg daily led to a significantly lower risk of ischemic cardiovascular events than placebo. (Funded by the Government of Quebec and others; COLCOT ClinicalTrials.gov number, NCT02551094.).
Philippe L. L’Allier, Jean‐Claude Tardif, Simon Kouz, David D. Waters, Rafael Díaz, Aldo Maggioni, Fausto J. Pinto, Habib Gamra, Ghassan S. Kiwan, Colin Berry, J. Lopez-Sendon, Wolfgang Köenig, Lucie Blondeau, Marie Claude Guertin, François Roubille
François Roubille, Nadia Bouabdallaoui, Simon Kouz, David D. Waters, Rafael Díaz, Aldo Maggioni, Fausto J. Pinto, Jean‐Claude Grégoire, Habib Gamra, Ghassan S. Kiwan, Colin Berry, José López‐Sendón, Wolfgang Köenig, Laurent Delorme, Meyer Elbaz, Pierre Coste, Mylène Provencher, Zohar Bassevitch, Lucie Blondeau, Philippe L. L’Allier, Marie‐Claude Guertin, Jean‐Claude Tardif
Jean‐Claude Tardif, Lambert Busque, Steve Geoffroy, Johanna Sandoval, Louis‐Philippe Lemieux Perreault, Ian Mongrain, Diane Valois, Marie-Josée Gaulin-Marion, Manuel Buscarlet, Sylvie Provost, Aldo Maggioni, Simon Kouz, Fausto J. Pinto, J. López‐Sendón, David D. Waters, Rafael Díaz, Habib Gamra, Ghassan S. Kiwan, Colin Berry, Wolfgang Köenig, Jean‐Claude Grégoire, Philippe L. L’Allier, Mylène Provencher,
Valtteri Muroke, David Rhainds, Mathieu R. Brodeur, C. Marchand, Daniel Charpentier, Valérie Pedneault-Gagnon, Patricia Rivest, Frédéric Latour, François Roubille, Rafael Díaz, Aldo Maggioni, Fausto J. Pinto, Simon Kouz, Colin Berry, J. López‐Sendón, Wolfgang Köenig, Mariève Cossette, Marie‐Claude Guertin, Éric Rhéaume, Jean‐Claude Tardif
Discussion(0)
No comments yet. Be the first to comment.